vs
Side-by-side financial comparison of Clearfield, Inc. (CLFD) and SBC Medical Group Holdings Inc (SBC). Click either name above to swap in a different company.
SBC Medical Group Holdings Inc is the larger business by last-quarter revenue ($39.6M vs $34.3M, roughly 1.2× Clearfield, Inc.). SBC Medical Group Holdings Inc runs the higher net margin — 35.9% vs -1.8%, a 37.7% gap on every dollar of revenue. On growth, Clearfield, Inc. posted the faster year-over-year revenue change (-3.2% vs -10.9%). SBC Medical Group Holdings Inc produced more free cash flow last quarter ($51.2M vs $-2.4M). Over the past eight quarters, Clearfield, Inc.'s revenue compounded faster (-3.5% CAGR vs -15.0%).
Clearfield, Inc. is a company headquartered in Minneapolis, Minnesota. The company produces fiber optic products.
SBC Medical Group Holdings Inc. is a leading Japan-headquartered healthcare provider primarily focused on aesthetic medicine, dermatology, and anti-aging wellness services. It operates an extensive network of clinics across Japan, catering to both domestic patients and international medical tourists, with core offerings including cosmetic surgery and non-invasive skincare treatments.
CLFD vs SBC — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $34.3M | $39.6M |
| Net Profit | $-614.0K | $14.2M |
| Gross Margin | 33.2% | 73.1% |
| Operating Margin | -5.3% | 32.5% |
| Net Margin | -1.8% | 35.9% |
| Revenue YoY | -3.2% | -10.9% |
| Net Profit YoY | 67.8% | 117.2% |
| EPS (diluted) | $-0.04 | $0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $34.3M | $39.6M | ||
| Q3 25 | $23.4M | $43.4M | ||
| Q2 25 | $49.9M | $43.4M | ||
| Q1 25 | $47.2M | $47.3M | ||
| Q4 24 | $29.7M | $44.4M | ||
| Q3 24 | $5.6M | $53.1M | ||
| Q2 24 | $48.8M | $53.1M | ||
| Q1 24 | $36.9M | $54.8M |
| Q4 25 | $-614.0K | $14.2M | ||
| Q3 25 | $-9.1M | $12.8M | ||
| Q2 25 | $1.6M | $2.5M | ||
| Q1 25 | $1.3M | $21.5M | ||
| Q4 24 | $-1.9M | $6.5M | ||
| Q3 24 | — | $2.8M | ||
| Q2 24 | $-447.0K | $18.5M | ||
| Q1 24 | $-5.9M | $18.8M |
| Q4 25 | 33.2% | 73.1% | ||
| Q3 25 | 53.2% | 70.6% | ||
| Q2 25 | 30.5% | 69.2% | ||
| Q1 25 | 30.1% | 79.7% | ||
| Q4 24 | 29.2% | 76.3% | ||
| Q3 24 | — | 81.5% | ||
| Q2 24 | 21.9% | 74.2% | ||
| Q1 24 | 7.7% | 72.1% |
| Q4 25 | -5.3% | 32.5% | ||
| Q3 25 | 10.3% | 36.6% | ||
| Q2 25 | 3.0% | 33.6% | ||
| Q1 25 | 0.6% | 51.1% | ||
| Q4 24 | -6.9% | 10.6% | ||
| Q3 24 | — | 26.1% | ||
| Q2 24 | -4.7% | 51.4% | ||
| Q1 24 | -26.4% | 44.6% |
| Q4 25 | -1.8% | 35.9% | ||
| Q3 25 | -38.8% | 29.6% | ||
| Q2 25 | 3.2% | 5.7% | ||
| Q1 25 | 2.8% | 45.4% | ||
| Q4 24 | -6.4% | 14.7% | ||
| Q3 24 | — | 5.3% | ||
| Q2 24 | -0.9% | 34.8% | ||
| Q1 24 | -16.0% | 34.2% |
| Q4 25 | $-0.04 | $0.15 | ||
| Q3 25 | $-0.65 | $0.12 | ||
| Q2 25 | $0.11 | $0.02 | ||
| Q1 25 | $0.09 | $0.21 | ||
| Q4 24 | $-0.13 | $0.05 | ||
| Q3 24 | — | $0.03 | ||
| Q2 24 | $-0.04 | $0.20 | ||
| Q1 24 | $-0.40 | $0.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $96.4M | $164.1M |
| Total DebtLower is stronger | — | $42.8M |
| Stockholders' EquityBook value | $249.7M | $248.3M |
| Total Assets | $268.1M | $380.4M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $96.4M | $164.1M | ||
| Q3 25 | $106.0M | $127.4M | ||
| Q2 25 | $117.2M | $152.7M | ||
| Q1 25 | $112.0M | $132.1M | ||
| Q4 24 | $113.0M | $125.0M | ||
| Q3 24 | $129.0M | $137.4M | ||
| Q2 24 | $123.8M | — | ||
| Q1 24 | $142.9M | — |
| Q4 25 | — | $42.8M | ||
| Q3 25 | — | $21.1M | ||
| Q2 25 | — | $7.1M | ||
| Q1 25 | — | $6.9M | ||
| Q4 24 | — | $6.6M | ||
| Q3 24 | $2.2M | $823.2K | ||
| Q2 24 | $2.1M | — | ||
| Q1 24 | — | — |
| Q4 25 | $249.7M | $248.3M | ||
| Q3 25 | $256.2M | $248.0M | ||
| Q2 25 | $264.5M | $244.6M | ||
| Q1 25 | $265.9M | $226.4M | ||
| Q4 24 | $267.4M | $195.1M | ||
| Q3 24 | $275.8M | $205.0M | ||
| Q2 24 | $274.6M | $8.8M | ||
| Q1 24 | $279.2M | $9.0M |
| Q4 25 | $268.1M | $380.4M | ||
| Q3 25 | $306.2M | $321.4M | ||
| Q2 25 | $314.7M | $315.3M | ||
| Q1 25 | $310.9M | $284.6M | ||
| Q4 24 | $303.2M | $266.1M | ||
| Q3 24 | $315.3M | $296.5M | ||
| Q2 24 | $318.1M | $19.5M | ||
| Q1 24 | $315.4M | $19.8M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.09× | ||
| Q2 25 | — | 0.03× | ||
| Q1 25 | — | 0.03× | ||
| Q4 24 | — | 0.03× | ||
| Q3 24 | 0.01× | 0.00× | ||
| Q2 24 | 0.01× | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.4M | $52.0M |
| Free Cash FlowOCF − Capex | $-2.4M | $51.2M |
| FCF MarginFCF / Revenue | -7.1% | 129.3% |
| Capex IntensityCapex / Revenue | 2.9% | 2.0% |
| Cash ConversionOCF / Net Profit | — | 3.66× |
| TTM Free Cash FlowTrailing 4 quarters | — | $23.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-1.4M | $52.0M | ||
| Q3 25 | — | $-20.9M | ||
| Q2 25 | $7.9M | $-8.3M | ||
| Q1 25 | $3.0M | $1.9M | ||
| Q4 24 | $7.2M | $-7.3M | ||
| Q3 24 | $22.2M | $5.0M | ||
| Q2 24 | $4.0M | $19.2M | ||
| Q1 24 | $-5.7M | $3.7M |
| Q4 25 | $-2.4M | $51.2M | ||
| Q3 25 | — | $-20.9M | ||
| Q2 25 | $7.5M | $-8.6M | ||
| Q1 25 | $654.0K | $1.7M | ||
| Q4 24 | $5.1M | $-7.9M | ||
| Q3 24 | $18.2M | $4.6M | ||
| Q2 24 | $2.8M | $18.3M | ||
| Q1 24 | $-7.7M | $3.0M |
| Q4 25 | -7.1% | 129.3% | ||
| Q3 25 | — | -48.3% | ||
| Q2 25 | 15.1% | -19.9% | ||
| Q1 25 | 1.4% | 3.5% | ||
| Q4 24 | 17.1% | -17.8% | ||
| Q3 24 | 323.0% | 8.7% | ||
| Q2 24 | 5.8% | 34.5% | ||
| Q1 24 | -20.8% | 5.4% |
| Q4 25 | 2.9% | 2.0% | ||
| Q3 25 | 2.0% | 0.1% | ||
| Q2 25 | 0.8% | 0.7% | ||
| Q1 25 | 5.1% | 0.5% | ||
| Q4 24 | 7.0% | 1.3% | ||
| Q3 24 | 71.4% | 0.8% | ||
| Q2 24 | 2.5% | 1.6% | ||
| Q1 24 | 5.3% | 1.3% |
| Q4 25 | — | 3.66× | ||
| Q3 25 | — | -1.63× | ||
| Q2 25 | 4.93× | -3.39× | ||
| Q1 25 | 2.30× | 0.09× | ||
| Q4 24 | — | -1.12× | ||
| Q3 24 | — | 1.77× | ||
| Q2 24 | — | 1.04× | ||
| Q1 24 | — | 0.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CLFD
Segment breakdown not available.
SBC
| Franchising | $10.3M | 26% |
| Medical Corporation Shobikai | $8.1M | 21% |
| Medical Corporation Nasukai | $7.2M | 18% |
| Management Services | $6.3M | 16% |
| Rental Services | $4.3M | 11% |
| Medical Corporation Association Furinkai | $3.0M | 8% |
| Japan Medical And Beauty Inc | $656.5K | 2% |
